RH

Rhian Sara HOLVEY

AL Astex Therapeutics Limited: 6 patents #43 of 199Top 25%
CL Cancer Research Technology Limited: 6 patents #58 of 493Top 15%
OC Otsuka Pharmaceutical Co.: 1 patents #681 of 1,273Top 55%
TC Taiho Pharmaceutical Co.: 1 patents #236 of 484Top 50%
Overall (All Time): #697,564 of 4,157,543Top 20%
7
Patents All Time

Issued Patents All Time

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
12077526 Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them Steven Howard, Benjamin David CONS, Jeffrey David ST. DENIS, Guillaume François PARRA, Kim Louise Hirst +11 more 2024-09-03
12071429 Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity Gianni Chessari, Steven Howard, Ildiko Maria Buck, Benjamin David CONS, Christopher Norbert Johnson +16 more 2024-08-27
11466016 Pharmaceutical compounds Christopher Norbert Johnson, Ildiko Maria Buck, Gianni Chessari, James Edward Harvey DAY, Hideto FUJIWARA +8 more 2022-10-11
11261171 Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity Gianni Chessari, Steven Howard, Ildiko Maria Buck, Benjamin David CONS, Christopher Norbert Johnson +16 more 2022-03-01
10981898 Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity Gianni Chessari, Steven Howard, Ildiko Maria Buck, Benjamin David CONS, Christopher Norbert Johnson +16 more 2021-04-20
10544132 Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity Gianni Chessari, Steven Howard, Ildiko Maria Buck, Benjamin David CONS, Christopher Norbert Johnson +16 more 2020-01-28
10526311 Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity Gianni Chessari, Steven Howard, Ildiko Maria Buck, Benjamin David CONS, Christopher Norbert Johnson +16 more 2020-01-07